PharmaFluidics Accelerates Commercialization with Fresh Funding
PharmaFluidics has announced it has raised 7.3 million euros in its bid to expand commercialization of its novel micro-chip device.
PharmaFluidics has announced it has raised 7.3 million euros in its bid to expand commercialization of its novel micro-chip device.
The financing round saw fresh investment from holding company FPIMâSFPI, as well as family offices Heran (Annie Vereecken) and RMM (Rudi Mariën). Existing investors PMV, Qbic, Theodorus, Innovatuin Fund, and Volksvermogen also reaffirmed their commitments with fresh funding.
The new funds will be used to further develop the pillar array technology platform, to expand the µPAC product range, and to scale up production and global sales.
“This funding will significantly boost our capacity to support our growth,” said Johan Devenyns, Managing Director of PharmaFluidics.
The company started shipping µPAC columns in September 2017, and have since served proteomics laboratories, medical centres, and pharmaceutical companies across Europe, the USA, and parts of Asia.
For more information, please visit www.pharmafluidics.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
